Rs 1,660 Puts — 3.9% Below Current Price — Draw 3,061 Contracts on Sun Pharmaceutical Industries Ltd

Put Options Event and Cash Market Context

The most active put strikes for Sun Pharmaceutical Industries Ltd on 27 Apr 2026 were Rs 1,680 (3,778 contracts), Rs 1,700 (3,576 contracts), and Rs 1,660 (3,061 contracts), all expiring on 28 Apr 2026. The underlying stock closed at Rs 1,728, up 7.10% on the day and outperforming its sector by 2.7%. The total turnover for these put contracts was substantial, with Rs 234.3 lakhs at the Rs 1,700 strike alone. Open interest at these strikes remains moderate, with 841 contracts at Rs 1,660 and 674 at Rs 1,680, indicating a mix of fresh and existing positions.

The stock’s strong intraday performance, touching a high of Rs 1,709, contrasts with the heavy put activity, raising the question: is this put buying a sign of hedging or bearish conviction?

Strike Price Analysis: Moneyness and Intent

The Rs 1,660 strike sits approximately 3.9% below the current price, placing these puts out-of-the-money (OTM). The Rs 1,680 and Rs 1,700 strikes are closer to at-the-money (ATM) territory, at 2.8% and 1.6% below the underlying price respectively. This distribution suggests that the put activity is concentrated near key support levels rather than deep in-the-money (ITM) strikes, which would typically indicate outright bearish bets or spread strategies.

Given the stock’s recent rally, OTM puts at Rs 1,660 and Rs 1,680 are more consistent with protective hedging, shielding gains from a potential pullback rather than signalling an expectation of a sharp decline. The Rs 1,700 strike, being nearer ATM, could reflect a blend of hedging and cautious positioning, especially with expiry imminent.

Interpreting the Put Activity: Hedging, Bearish Positioning, or Put Writing?

Put options inherently carry ambiguous signals. The three main interpretations are: directional bearish bets (put buying anticipating a fall), hedging of existing long positions (protective puts), or put writing (selling puts to collect premium, implying bullish or neutral outlook).

In this case, the stock’s 7.10% gain on the day and its position above the 5-day moving average but below longer-term averages suggest a rally that may still be vulnerable to short-term corrections. The concentration of put contracts at strikes slightly below the current price aligns with a hedging motive, as investors seek to protect recent gains without signalling a full bearish conviction. The open interest levels, while not extremely high, indicate some fresh positioning but also ongoing adjustments to existing hedges.

Put writing appears less likely given the high turnover and relatively low open interest ratios (e.g., 3,061 contracts traded vs. 841 open interest at Rs 1,660), which points to active buying rather than premium collection. However, some put selling cannot be ruled out entirely, especially at the Rs 1,700 strike where open interest is lower relative to contracts traded.

The options data alone is ambiguous; the cash market data resolves the ambiguity — how does the recent price action influence the interpretation of this put activity?

Open Interest and Contracts Analysis

The ratio of contracts traded to open interest at the Rs 1,660 strike is approximately 3.6:1, indicating significant fresh activity rather than mere rollover or position squaring. Similar ratios at Rs 1,680 and Rs 1,700 strikes reinforce this view. This fresh buying suggests active hedging or new bearish positioning rather than passive adjustments.

However, the overall open interest remains moderate, which tempers the scale of the put activity relative to the stock’s liquidity and market cap. The stock’s liquidity, with a 5-day average traded value supporting trades of around Rs 13.92 crores, ensures that these option trades are meaningful but not extraordinary in the broader context.

Cash Market Context: Moving Averages and Delivery Volumes

Sun Pharmaceutical Industries Ltd currently trades above its 5-day moving average but remains below its 20-day, 50-day, 100-day, and 200-day moving averages. This positioning suggests a short-term rally within a longer-term consolidation or downtrend. The Rs 1,660 put strike roughly corresponds to a support zone below the 50-day moving average, consistent with a protective hedge against a pullback to technical support.

Delivery volumes on 24 Apr surged to 63.23 lakh shares, a 234% increase over the 5-day average, signalling strong investor participation in the recent rally. Yet, the weighted average price on 27 Apr was closer to the day’s low, indicating some selling pressure intraday. This mixed delivery and price action may explain why investors are seeking downside protection through puts — should investors consider hedging their positions or is the rally sustainable?

Fundamental and Sector Overview

Sun Pharmaceutical Industries Ltd is a large-cap leader in the Pharmaceuticals & Biotechnology sector, with a market capitalisation of Rs 3,88,332 crores. The sector gained 2.32% on the day, while the Sensex rose 0.59%, underscoring the stock’s relative strength. This fundamental backdrop supports the view that the put activity is more likely protective hedging amid a rally rather than outright bearish positioning.

Conclusion: Protective Hedging Dominates the Put Activity

The put option activity in Sun Pharmaceutical Industries Ltd on 27 Apr 2026, concentrated at strikes 1.6% to 3.9% below the current price, combined with the stock’s strong intraday gains and technical positioning, points primarily to protective hedging. Investors appear to be safeguarding recent gains against a potential short-term pullback rather than positioning for a sharp decline.

While some bearish bets or put writing cannot be entirely ruled out, the data suggests that the put activity is a measured response to recent volatility and delivery volume patterns rather than a signal of imminent weakness. The stock’s position above the 5-day moving average but below longer-term averages further supports this interpretation, as the Rs 1,660 strike aligns with a plausible support level.

Given this nuanced picture, should investors be hedging their positions in Sun Pharmaceutical Industries Ltd or does the rally have more room to run?

Key Data at a Glance

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today